Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-08-27Clinical Trial Update: Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients
This clinical trial update describes the experiences of 6- to 12-year-old pediatric cancer patients balancing school attendance with ongoing…
-
CLINICAL_TRIALS research · 2015-08-26Clinical Trial Update: Exercise Post Bone Marrow Transplant [NA]
Clinical trial update from the University of British Columbia on an exercise program after bone marrow transplant for leukemia. The current …
-
CLINICAL_TRIALS trial_result · 2015-08-24Clinical Trial Update: Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer [Phase 2]
Phase 2 trial evaluating a conditioning regimen of fludarabine, cyclophosphamide, and total-body irradiation for patients undergoing donor b…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED) [Phase 2]
Completed Phase 2 study of AP23573 (ridaforolimus) in patients with relapsed or refractory hematologic malignancies, including leukemia, mye…
-
CLINICAL_TRIALS research · 2015-08-13Clinical Trial Update: Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor
Analysis of EBMT registry data evaluates off-label use of plerixafor in hematopoietic cell transplantation, summarizing indications and obse…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2015-07-28Clinical Trial Update: Italian Platelet Technology Assessment Study [Phase 3]
The Phase 3 Italian Platelet Technology Assessment Study, sponsored by Centro Nazionale Sangue, evaluating Leukemia and Lymphoma indications…
-
CLINICAL_TRIALS trial_result · 2015-07-21Clinical Trial Update: Efficacy of a Patient Education Video [NA]
This entry summarizes a terminated clinical trial evaluating the efficacy of a patient education video for leukemia and other malignant neop…
-
CLINICAL_TRIALS trial_result · 2015-07-10Clinical Trial Update: Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes [Phase 2]
Phase 2 clinical trial evaluating arsenic trioxide in combination with gemtuzumab ozogamicin for advanced myelodysplastic syndromes (and ass…
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia [Phase 4]
A Phase 4 pilot safety study evaluating weekly 10 mg/kg doses of AmBisome (liposomal amphotericin B) as antifungal prophylaxis in patients u…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
This entry reports a completed clinical trial evaluating the psychosexual impact of cancer-related infertility in women and the role of thir…
-
CLINICAL_TRIALS trial_result · 2015-06-30Clinical Trial Update: 5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial of azacitidine (Vidaza) in chronic lymphocytic leukemia was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-22Clinical Trial Update: Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies [Phase 2]
Phase II cancer trial of TPA plus Dexamethasone and CMT in leukemia was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-06-17Clinical Trial Update: Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701) [Phase 1, Phase 2]
Phase 1/2 trial of a Farnesyl Protein Transferase Inhibitor in leukemia and myelodysplastic syndromes has completed, sponsored by Merck Shar…
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Prophylactic White Cell Transfusions Versus Therapeutic White Cell Transfusions in Patients With Leukemia [Phase 2]
Phase 2 trial comparing prophylactic versus therapeutic white blood cell transfusions in leukemia patients was terminated, with results post…
-
CLINICAL_TRIALS withdrawal · 2015-06-08Clinical Trial Update: Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment [Phase 1]
Phase 1 trial evaluating total marrow and total lymph node irradiation with fludarabine and melphalan followed by donor stem cell transplant…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: A Standardized Nursing Intervention Protocol for HCT Patients [NA]
This document reports the completion of a clinical trial evaluating a standardized nursing intervention protocol for hematopoietic cell tran…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant [NA]
Clinical trial update describing a completed study evaluating blood changes in patients at high risk of cytomegalovirus infection after dono…
-
CLINICAL_TRIALS withdrawal · 2015-05-29Clinical Trial Update: Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers
A clinical trial evaluating perceived burden in late-stage cancer patients and their caregivers has been withdrawn.
-
CLINICAL_TRIALS research · 2015-05-27Clinical Trial Update: Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT) [Phase 2]
Phase 2 study evaluating myeloablative cord blood transplantation for leukemia and lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma [Phase 1]
Update on a Phase 1 clinical trial of the LMB-2 immunotoxin in young patients with relapsed or refractory leukemia or lymphoma; the study ha…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia [Phase 1]
Phase 1 study evaluating UCN-01 in combination with fludarabine for recurrent or refractory leukemia or lymphoma; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Immunotoxin in Treating Patients With Leukemia or Lymphoma [Phase 1]
This is a Phase 1 clinical trial update describing an immunotoxin used to treat leukemia or lymphoma. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma [Phase 1]
A Phase 1 study sponsored by the National Cancer Institute evaluating arsenic trioxide in pediatric patients with refractory leukemia or lym…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer [Phase 1]
A Phase 1 study evaluating perifosine in patients with refractory solid tumors and hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Unrelated Donor Transplant for Malignant and Non-Malignant Disorders [Phase 2]
Phase 2 trial of unrelated donor transplantation for malignant and non-malignant hematologic disorders; the study status is terminated.